StreetInsider.com News Articles

Piper Sandler's Key Takeaways From CRT 2026

Tue, 10 Mar 2026 08:35:59 -0400

Piper Sandler analyst Adam C. Maeder shares Key Takeaways From the Cardiovascular Research Technologies meeting.

The analyst commented: "We attended the CRT (Cardiovascular Research Technologies) Meeting. Our takeaways include: (1) There was lots of discussion around the MDT low-risk TAVR data and the reintervention signal seen at 6 and 7-years. We think MDT has some plausible explanations/rebuttals, however, we think the headlines will carry-the-day and we expect some share to change hands (we see EW as the primary beneficiary). (2) Roughly 3/4 of the physicians that voted during the “CRT Predicts” session that CHAMPION-AF will meet its primary endpoints later this

Piper Sandler's Key Takeaways From CRT 2026

Tue, 10 Mar 2026 08:35:59 -0400

Piper Sandler analyst Adam C. Maeder shares Key Takeaways From the Cardiovascular Research Technologies meeting.

Piper Sandler's Key Takeaways From CRT 2026

Tue, 10 Mar 2026 08:35:59 -0400

Piper Sandler analyst Adam C. Maeder shares Key Takeaways From the Cardiovascular Research Technologies meeting.

Piper Sandler's Key Takeaways From CRT 2026

Tue, 10 Mar 2026 08:35:59 -0400

Piper Sandler analyst Adam C. Maeder shares Key Takeaways From the Cardiovascular Research Technologies meeting.

Piper Sandler's Key Takeaways From CRT 2026

Tue, 10 Mar 2026 08:35:59 -0400

Piper Sandler analyst Adam C. Maeder shares Key Takeaways From the Cardiovascular Research Technologies meeting.

Form 4 Edwards Lifesciences For: Mar 02 Filed by: BOBO DONALD E JR

Mon, 02 Mar 2026 17:51:00 -0400

si-local-file:///var/storage/secattach/20260302/26094224.html

Form 4 Edwards Lifesciences For: Mar 02 Filed by: BOBO DONALD E JR

Mon, 02 Mar 2026 17:51:00 -0400

si-local-file:///var/storage/secattach/20260302/26094224.html

Form 4 Edwards Lifesciences For: Feb 25 Filed by: BOBO DONALD E JR

Thu, 26 Feb 2026 19:34:00 -0400

si-local-file:///var/storage/secattach/20260226/26073519.html

Form 4 Edwards Lifesciences For: Feb 25 Filed by: BOBO DONALD E JR

Thu, 26 Feb 2026 19:34:00 -0400

si-local-file:///var/storage/secattach/20260226/26073519.html

Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR

Thu, 26 Feb 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260226/26070712.html

Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR

Thu, 26 Feb 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260226/26070712.html

Edwards Lifesciences sets goal to help 2 million more patients by 2030

Thu, 26 Feb 2026 09:16:27 -0400

Edwards Lifesciences Corporation (NYSE: EW) announced an expanded goal for its Every Heartbeat Matters initiative to help 2 million additional patients worldwide access structural heart treatment by 2030.

The medical device company stated that its global health initiative focuses on increasing access to diagnosis and treatment for underserved structural heart patients, particularly in low- and middle-income countries where care barriers exist. Since 2014, Every Heartbeat Matters and its charitable partners have impacted more than 4 million underserved structural heart patients globally, according to the company.

"For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Thu, 26 Feb 2026 09:15:00 -0400

IRVINE, Calif.--(BUSINESS WIRE)-- At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access lifesaving structural heart treatment by the end of 2030.

“For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients with structural

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Thu, 26 Feb 2026 09:15:00 -0400

“For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients with structural

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Thu, 26 Feb 2026 09:15:00 -0400

“For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients with structural

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Thu, 26 Feb 2026 09:15:00 -0400

“For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients with structural

Form 10-K Edwards Lifesciences For: Dec 31

Wed, 25 Feb 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260225/26060035.html

Form 10-K Edwards Lifesciences For: Dec 31

Wed, 25 Feb 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260225/26060035.html

Form 4 Edwards Lifesciences For: Feb 22 Filed by: Lippis Daniel J.

Mon, 23 Feb 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260223/26044493.html

Form 4 Edwards Lifesciences For: Feb 22 Filed by: Lippis Daniel J.

Mon, 23 Feb 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260223/26044493.html

Form 4 Edwards Lifesciences For: Feb 22 Filed by: Dahl Andrew M.

Mon, 23 Feb 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260223/26044495.html

Form 4 Edwards Lifesciences For: Feb 22 Filed by: Dahl Andrew M.

Mon, 23 Feb 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260223/26044495.html

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Thu, 19 Feb 2026 07:05:00 -0400

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences:

Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference
Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference

A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Thu, 19 Feb 2026 07:05:00 -0400

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences:

Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference
Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference

A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Thu, 19 Feb 2026 07:05:00 -0400

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences:

Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference
Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference

A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion